Skip to main content
Clinical Trials/NCT02892136
NCT02892136
Active, Not Recruiting
N/A

Technical Development for Pediatric Cardiovascular MRI

Children's National Research Institute1 site in 1 country5,000 target enrollmentMay 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Congenital Heart Disease
Sponsor
Children's National Research Institute
Enrollment
5000
Locations
1
Primary Endpoint
To evaluate innovative noninvasive MRI techniques suitable for evaluating pediatric patients with cardiovascular disease, congenital cardiac disease, and fetal organ analysis including cardiac structure, function, and physiology.
Status
Active, Not Recruiting
Last Updated
4 years ago

Overview

Brief Summary

This study will explore new ways of using magnetic resonance imaging (MRI) to evaluate pediatric patients with cardiovascular disease,congenital heart disease in patients of all ages, fetuses undergoing clinically indicated MR imaging.

Detailed Description

The purpose of this protocol is to allow development and testing of new MRI techniques suitable for evaluating patients with cardiovascular disease, congenital heart disease, fetal cardiac structure, function, and physiology, and other fetal organ analysis. Individuals referred to Children's National Medical Center for a clinically indicated cardiac MRI or cardiac catheterization by their primary referring cardiologist or obstetrician, and who are enrolled in this study may also undergo additional research imaging. Since such technical development work often depends on preliminary studies in healthy volunteers, the protocol also recruits healthy subjects.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
December 2026
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Children's National Research Institute
Responsible Party
Principal Investigator
Principal Investigator

Russell Cross

MD

Children's National Research Institute

Eligibility Criteria

Inclusion Criteria

  • Clinically indicated exams
  • Patients who are undergoing a medically indicated MRI scan or cardiac catheterization procedure
  • Patients who are medically judged to have no contraindications to MRI scan
  • Age inclusion: infant to adult
  • Written informed consent and assent, when applicable
  • Written informed consent from any normal volunteer 8 years of age or older for a noncontrast, nonsedated cardiac MRI
  • Normal adult volunteer to undergo cardiac MRI with contrast agent
  • Fetal exams
  • Age inclusion:18 years and older
  • Second or third trimester (greater than 13 weeks)

Exclusion Criteria

  • All patients who are medically judged to have contraindication(s) to MRI scanning will be excluded. Contraindications include implanted metal devices which are contraindicated for MRI scanning:
  • Central nervous system aneurysm clips;
  • Implanted neural stimulator;
  • Implanted cardiac pacemaker or defibrillator;
  • Cochlear implant;
  • Ocular foreign body (e.g. metal shavings);
  • Implanted Insulin pump;
  • Metal shrapnel or bullet.
  • Exclusion criteria for Bicycle Stress MRI
  • Myocardial infarction within 24 hours

Outcomes

Primary Outcomes

To evaluate innovative noninvasive MRI techniques suitable for evaluating pediatric patients with cardiovascular disease, congenital cardiac disease, and fetal organ analysis including cardiac structure, function, and physiology.

Time Frame: through study completion, an average of 1 year

Secondary Outcomes

  • Natural history of congenital heart disease(through study completion, an average of 1 year)

Study Sites (1)

Loading locations...

Similar Trials